Les spumavirus (SV) sont des rétrovirus exogènes de la sous-famille des Spumavirinae appartenant à la famille des Retroviridae. L’infection naturelle chez les primates non humains (PNH) est décrite dans la nature et en captivité, avec 75 à 100% de singes adultes infectés. Chez les PNH, la transmission des SV se fait à travers des morsures très graves. Par ailleurs, ces virus ont été isolés chez des travailleurs de zoo, exposés aux animaux infectés dans le cadre de leur travail. Récemment, des études ont aussi montré l’infection dans le milieu naturel chez des chasseurs au Cameroun. Cependant, aucune pathologie n’a jamais pu être associée à l’infection par ces virus. Au Gabon, les infections par des SV n’ont été que très peu étudiées. Les objectifs de cette thèse sont donc :1) D’évaluer au Gabon, la prévalence des SV dans la colonie de Mandrills en captivité au centre de primatologie (CDP) du CIRMF, ainsi que dans la nature chez un grand nombre d’espèces de primates non humains ;2) De caractériser sur le plan moléculaire les souches SV circulant au Gabon ;3) D’identifier chez des personnes mordues par un PNH des cas de transmission interespèces.Dans la première partie de ce travail, nous avons montré que 83% (70/84) des mandrills du CDP (38 males et 46 femelles) et 60% (9/15) des mandrills sauvages étaient infectés par le SV. L’infection augmentait avec l’âge et la différence entre les males et les femelles n’était pas significative (84% et 82%, respectivement). Un fragment de 425pb de l’integrase a été amplifié dans 60/69 et 53 nouvelles séquences ont été isolées. L’analyse phylogénétique a mis en évidence la circulation de 11 souches différentes dans la colonie, toutes étroitement liées sauf une. La confirmation de ces résultats à l’aide de séquences de virus chez des mandrills sauvages démontre l’existence de deux groupes de mandrills (nord et sud) localisés de part et d’autre du fleuve Ogooué. En plus, nous avons étudié 497 échantillons de plasma et tissus prélevés chez 13 espèces simiennes dans la nature. L’analyse sérologique a montré l’infection par SV chez 10.8% (31/286). Le fragment de l’integrase a été caractérisé dans 38/497 échantillons, avec la description de nouvelles infections naturelles chez les C. solatus, C. nictitans et C. cephus. Dans la deuxième partie, nous avons décrit l’infection chez 20% (4/20) des travailleurs du CDP. La caractérisation moléculaire a été faite chez deux d’entre eux: l’un a été mordu il y a 10 ans par un mandrill clairement identifié, et l’autre par un macaque 25 ans auparavant. En milieu naturel, nous avons testé 78 personnes mordues par un PNH. Au total, 19 personnes mordues (24%) étaient séropositives pour le SV. Sur ces 19 individus, 15 séquences virales ont été obtenues dont 12 de gorilles, 2 de chimpanzés et une de cercopithèque. Ces résultats montrent que les PNH du Gabon sont infectés par les SV et que la transmission inter espèces des SV intervient chez des personnes mordues par ces animaux. / Foamy viruses are members of the Spumavirus genus of the Retroviridae family. These complex exogenous retroviruses are highly prevalent in several animal species, including nonhuman primates (NHP). The seroprevalence of antibodies to Simian foamy virus (SFVs) in captive adult NHP populations can reach 75-100%. SFV infection has been reported in people occupationally exposed to nonhuman primates in zoos. Recently, naturally acquired SFV infections were described in a group of hunters living in Cameroon, central Africa.In Gabon, foamy viruses are less studied. In our study, we evaluated the natural history of SFV in a free-ranging colony of mandrills (CIRMF primate center) and in mandrills living in natura in Gabon (central Africa). We also determined the SFV prevalence in a series of 497 NHP living in different parts of Gabon. Lastly, we investigated the possible transmission of SFVs to humans.First, SFV infection was determined by specific serological (Western blot) and molecular (nested PCR of the integrase region in the polymerase gene) assays. Seropositivity for SFV was found in 70/84 (83%) captive and 9/15 (60%) wild-caught mandrills. The 425-bp SFV integrase fragment was detected in peripheral blood DNA from 53 captive and 8 wild-caught mandrills.Sequence and phylogenetic studies demonstrated the presence of two distinct strains of mandrill SFV, one clade including SFVs from mandrills living in the northern part of Gabon and the second consisting of SFV from animals living in the south. Among the NHP, 10.8% (31/286) of the plasma/sera were SFV seropositive. Integrase gene was characterized in 38 samples with novel SFVs in several species of Cercopithecus.Second, the presence of SFV was also evaluated in 20 people who worked closely with mandrills and other NHP. Integrase region of 425 bp was found in 2/20 (10%) humans. One man who had been bitten 10 years earlier by a mandrill and another bitten 22 years earlier by a macaque were found to be SFV-infected, both at the Primate Centre. Comparative sequence analysis of the virus from the first man and from the mandrill showed nearly identical sequences, indicating genetic stability of SFV over time. The second man had a sequence close to SFVmac sequences. Of the 78 people, mostly hunters, who had been bitten or scratched by NHPs, 19 were SFV seropositive, with 15 cases confirmed by PCR. All but one were infected with ape SFV. We thus found novel SFV strains in NHPs in Gabon and high interspecies transmission of SFVs from gorilla bites.

No description available.

This study examined object permanence in Sumatran orangutans (Pongo abelii), Western lowland gorillas (Gorilla gorilla gorilla), and black-and-white-ruffed lemurs (Varecia variegata) at Zoo Atlanta. A literature review reveals two main issues with object permanence research in non-human primates. One of the issues is that it is difficult to make valid comparisons between different species because very few studies have been conducted using appropriate controls. Thus, one of the goals of this study was to conduct control trials for all tasks in the traditional object permanence test battery, in order to reliably assess and compare performance in the species under study. The second issue is concerned with the finding that all of the non-human primate species tested so far have failed one of the more difficult tasks in the test battery, namely the non-adjacent double invisible displacement task. It has been hypothesized that this performance limitation is a result of the manner in which the task is presented. Thus, the second goal of this study was to modify the existing methodology and present the task to gorillas and orangutans in locomotive space to see if performance improves. This is the first study to present this task to non-human primate species in locomotive space. This study found that orangutans were the only species to reliably pass most tasks in the traditional object permanence test battery. Black-and-white ruffed lemurs failed most visible and invisible displacement tasks. Owing to the small sample size of gorillas in this study, further research is required before any firm conclusions can be made about the ability of this species to solve visible and invisible displacement tasks in the traditional object permanence test battery. Presenting the boxes in locomotive space to gorillas and orangutans did not improve performance on the non-adjacent double invisible displacement task. Further research is required to resolve the question of whether this performance limitation is a result of the manner in which the task was presented.

Sanofi Pasteur travaille depuis plus de 20 ans au développement d’un vaccin contre la Dengue, maladie virale pouvant présenter des formes sévères. Ce vaccin, dénommé Dengue CYD est composé de quatre virus recombinants basés sur la souche vaccinale contre la Fièvre Jaune dans laquelle les gènes codant les protéines prM et E ont été remplacés par ceux des différents sérotypes de virus Dengue.Dans les études décrites ici, nous avons démontré la stabilité génétique des souches vaccinales au cours des étapes de production, et nous avons mis au point un système de qRT-PCR pour quantifier le génome viral afin de caractériser les lots et suivre les virémies post-vaccinales.De plus, différentes études précliniques menées chez le macaque ont permis :1) d’évaluer l’immunogénicité du vaccin après immunisation par différentes formulations vaccinales et selon différents schémas visant à réduire les interférences entre les sérotypes. L’administration de vaccins bivalents complémentaires à des sites anatomiques différents ou de façon séquentielle, l’établissement d’une pré-immunité hétérologue, une moindre dose relative du sérotype vaccinal dominant ou l’administration d’un rappel à un an ont ainsi permis de mettre en évidence des pistes d’amélioration du schéma vaccinal.2) d’évaluer la biodistribution et l’excrétion du vaccin afin de confirmer son innocuité.3) de tester la neutralisation d’un panel de souches virales par des sérums des singes vaccinés pour montrer que les anticorps induits par le vaccin peuvent neutraliser des souches Dengue circulantes d’origines géographiques et de génotypes variés.Enfin, l’absence de risque de dissémination du virus dans l’environnement via les tiques, arthropodes vecteurs d’autres Flavivirus, a été confirmée.Ces études ont permis d’apporter des éléments démontrant l’intérêt du vaccin Dengue CYD pour lancer des études cliniques et compléter les dossiers réglementaires visant à l’enregistrement du vaccin Dengvaxia® / Sanofi Pasteur has been working for more than 20 years to develop a vaccine against Dengue, viral disease that can cause life-threatening forms. The CYD Dengue vaccine is a tetravalent recombinant virus based on Yellow fever vaccine strain in which genes encoding prM and E proteins have been replaced by the corresponding genes from the different Dengue virus serotypes.In the studies described here, we demonstrated the genetic stability of the vaccine strains during the manufacturing steps and we set-up a qRT-PCR system to quantify viral genome in order to characterize batches and to follow post-vaccination viremia.In addition, different pre-clinical studies were conducted in macaques in order:1) To evaluate the vaccine immunogenicity after immunizations according to different schedules and formulations aiming at decreasing interferences between serotypes. Different parameters were shown to improve vaccine immunogenicity, such as administration of complementary bivalent vaccines at separate anatomical sites or sequentially, establishment of a heterologous pre-immunity, adaptation of the formulation by decreasing the dose of the dominant serotype or administration of a 1-year booster.2) To evaluate the biodistribution and shedding of the vaccine to confirm its safety3) To test neutralization by vaccinated-monkey sera of a panel of circulating viral strains to demonstrate that antibodies elicited by the vaccine should neutralize Dengue strains from different geographical origins and genotypesFinally, the absence of risk of dissemination of the virus in the environment via ticks, i.e. arthropods responsible for transmission of other Flaviviruses, was confirmed.These studies brought elements demonstrating the interest of the CYD Dengue vaccine to allow starting clinical trials and filing of technical dossiers supporting Dengvaxia® submission and registration

Les virus entérotropes sont des virus ubiquitaires infectant une large catégorie de vertébrés dont l’homme et les primates non-humains (PNHs). Ils se transmettent principalement par voie féco-orale directe ou indirecte à la suite de laquelle ils atteignent les entérocytes et s’y multiplient. Bien que parfois asymptomatiques, les infections causées par les virus entérotropes peuvent se manifester par des gastroentérites très fréquentes chez les enfants de moins de 5 ans. Ces mêmes virus peuvent être responsables de pathologies sévères telles que les maladies respiratoires, encéphalitiques, cardiaques, neurologiques. À partir des années 1950, de nombreux virus entérotropes ont été isolés de tissus de PNHs couramment utilisés en cultures cellulaires et en recherche biomédicale. Dès lors, de nombreuses études ont été conduites sur la caractérisation des virus entérotropes principalement chez les PNHs captifs ou en contact avec l’homme. En milieu naturel, en dehors des entérovirus et des adénovirus, leur circulation, leur épidémiologie et leur diversité restent encore peu connues. L’objectif de cette thèse est donc de rechercher et caractériser les virus entérotropes chez les PNHs d’Afrique Centrale. Ainsi à partir de 600 échantillons de fèces de PNHs collectés dans des forêts et réserves naturelles au Gabon, nous avons pu mettre en évidence la circulation de différentes espèces d’entérovirus (EVs) chez les mandrills et les chimpanzés. Cette caractérisation a également permis de mettre en évidence des EVs proches d’EVs infectant l’homme ainsi que deux nouveaux sérotypes chez un chimpanzé et chez un mandrill. Nous avons également mis en évidence un astrovirus (AstV) totalement divergent d’AstVs référencés chez un gorille. En dehors de leur circulation en milieu naturel, les virus entérotropes sont également présents chez les PNHs en contact fréquents avec l’homme. De ce fait à partir d’échantillons fécaux d’un groupe de 12 chimpanzés du Sanctuaire de Tchimpounga, nous avons caractérisé l’EV-C99 responsable de cas de paralysie chez l’homme et probablement responsable de celle observée chez un chimpanzé. De plus, deux sapovirus (SaVs) très proches d’un SaV identifié chez l’homme ont également été caractérisés. L’Afrique Centrale est donc caractérisée par une diversité de virus entérotropes qui circulent chez les PNHs. L’identification chez les PNHs de virus entérotropes proches en milieu naturel de ceux infectant l’homme soulève l’existence d’une probabilité de transmission inter-espèce entre les PNHs et l’homme dont le sens reste encore à déterminer. Par contre chez les PNHs du sanctuaire, la susceptibilité à ces virus humains peut être responsable de pathologies graves comme la paralysie observée chez les chimpanzés. / The enteric viruses are ubiquitous virus infecting a broad range of vertebrates, including humans and non-human primates (NHPs). They are spread by direct or indirect fecal-oral route following which they reach the enterocytes and multiply. Even though infections caused by these viruses are asymptomatic, enteric viruses could be responsible for frequent gastroenteritis in children under 5 years of age. These viruses may be responsible for severe pathologies such as respiratory, encephalitic, cardiac and neurological diseases. In the 1950s, many viruses have been isolated from NHPs species commonly used in cell culture and biomedical research. Since, many studies have been conducted to characterize, then enteric viruses have been mainly identified in captive NHPs or those living in close contact with humans. Little is known concerning the circulation, epidemiology and diversity of enteric viruses in the wild, except for enteroviruses and adenoviruses. The objective of this thesis is to investigate and characterize the enteric virus in NHPs of Central Africa. Thus from 600 samples of feces of NHPs collected in natural forests and reserves in Gabon, we highlighted the circulation of different species enteroviruses (EVs) in mandrills and chimps. We also identified EVs close to those infecting humans as well as two new serotypes in a chimpanzee and in a mandrill. We have highlighted an astrovirus (AstV) completely divergent from those referenced in a gorilla. Apart from their outstanding natural environment, enteric viruses are also present in NHPs in frequent contact with humans. Therefore fecal samples from a group of 12 chimpanzees from the Tchimpounga Sanctuary, we characterized the EV-C99 responsible for cases of paralysis in humans and probably responsible for that observed in a chimpanzee. In addition, two sapovirus (SaVs) very close to a SaV identified in humans have also been characterized. Central Africa is therefore characterized by a diversity of enteric virus circulating in NHPs. The identification in the wild of enteric virus in NHPs close to those infecting humans raises probability of cross-species transmissions between NHPs and humans whose sense remains to be determined. However in NHPs in the sanctuary, susceptibility to these human viruses can be responsible for severe diseases such as paralysis observed in chimpanzee.

La neurohormone ocytocine (OT) est de plus en plus étudiée pour son potentiel thérapeutique dans les troubles du comportement social, comme l'autisme, qui sont associés à une dérégulation de plusieurs systèmes de neurotransmission, notamment l'OT et la sérotonine (5-HT). Dans ce cadre, une étape importante afin de développer des médicaments basés sur des mécanismes biologiques est de caractériser les interactions entre l'OT et les autres neurotransmetteurs. La littérature sur les rongeurs montre que la relation entre OT et 5-HT est fortement impliquée dans plusieurs aspects du comportement social. Par ailleurs, nous avons récemment montré chez le sujet sain que le fonctionnement du récepteur 5-HT 1A (5-HT1AR) est modifié suite à l'administration d'OT.neuroJ'ai donc réalisé une première expérience chez des patients autistes en utilisant le scanner TEP avec le radiotraceur [18F]MPPF (spécifique du 5-HT1AR). Aucune différence n'est apparue, à l'état basal, entre 18 patients autistes et 24 sujets contrôles. Par ailleurs, l'OT n'a pas modifié le système 5-HT1AR. Enfin, alors qu'une corrélation entre la densité de 5-HT1AR et le volume de matière grise du striatum a été observé dans le groupe contrôle, cette relation était absente dans le groupe de patients. Ces résultats suggèrent une altération subtile du 5-HT1AR, ne pouvant être détectée qu'au niveau fonctionnel.Parce que le scanner TEP ne permet pas de dire si les changements observés sont dus à une libération de sérotonine ou à une modification directe du récepteur, j'ai réalisé une deuxième expérience chez 3 macaques rhésus, avec le [18F]MPPF et le [11C]DASB (marquant le transporteur de la 5-HT). Par rapport au placebo, l'OT injectée dans le ventricule latéral a significativement augmenté la liaison du [18F]MPPF dans l'amygdale et l'insula tandis que la liaison du [11C]DASB diminuait dans ces mêmes régions. Ainsi, nous pouvons dire que l'OT a provoqué la libération de 5-HT ainsi qu'une modification du 5-HT1AR dans ces régions importantes pour les comportements socio-émotionnels. Une étude par autoradiographie a confirmé cette interprétation.Ces expériences montrent qu'il existe une action régulatrice de l'OT sur la 5-HT chez le primate, mais que ce mécanisme est dérégulé chez les patients avec autisme. Cela ouvre donc la voie à l'investigation de traitements combinés exerçant un effet sur ces deux neurotransmetteurs / The neurohormone oxytocin (OT) is increasingly studied for its therapeutic potential in social disorders, like autism, which are associated with the deregulation of several neurotransmission systems, including OT and serotonin (5-HT). Hence investigating OT’s interactions with other neurotransmitters is a relevant step towards mechanism-based treatments. Studies in rodents demonstrated that the interaction between OT and 5-HT, is critical for several aspects of social behaviour. Moreover, using PET-scan in humans we have recently found that 5-HT 1A receptor (5-HT1AR) function is modified after intra-nasal oxytocin intake. Thus I performed a first experiment in which intra-nasal OT was administered to patients with autism undergoing a [18F]MPPF (a 5-HT1AR radiotracer) PET scanner, in order to study their basal serotonergic system and to look if the oxytocin modulates the 5-HT1AR system. I found no differences of baseline 5-HT1AR concentration between 18 autistic subjects and 24 controls. Critically, in patients, OT did not induce changes on the 5-HT1AR system. Moreover, in controls, there was a correlation between 5-HT1AR and grey matter volume in the striatum, that was not observed in patients. These results suggest a subtle disruption of patients’ serotonergic system, that can only be seen at the functional level. Because PET scan does not tell us if the observed modification is due to a change in 5-HT1AR or 5-HT concentration, I performed a second PET scan experiment on 3 macaque monkeys, using [18F]MPPF and [11C]DASB, that marks the serotonin transporter. Compared to placebo, OT injections in the lateral ventricle significantly reduced [11C]DASB binding potential in right amygdala, insula and hippocampus whereas [18F]MPPF binding potential increased in right amygdala and insula. Thus we reproduced results obtained in healthy humans and extended it by suggesting that OT provokes the release of 5-HT in key limbic regions involved in socio-emotional processing. These results were confirmed with autoradiography.Taken together, these experiments indicate that OT modulates 5-HT release in primates, but this mechanism is disrupted in patients with autism. This opens ways to investigate combined OT/5-HT treatments, especially since FDA approved drugs targeting the two systems are already available for use in patients with autism

L’impulsivité décisionnelle est une des multiples dimensions de l’impulsivité. Elle est définie comme la préférence d’une petite récompense immédiate à une grande récompense différée, et dérive du fait que la valeur que l’on attribue à une récompense diminue avec le temps. Quand la dévaluation temporelle est excessive, l’impulsivité de choix devient un symptôme présent dans de nombreuses pathologies. Le striatum, structure cérébrale profonde composée de trois sous-territoires, le noyau caudé, le striatum ventral et le putamen, est un élément clé dans le traitement de l’impulsivité décisionnelle. En effet, il constitue la principale cible de la dopamine, connue pour être un modulateur de l’impulsivité. En lien avec le cortex, le striatum antérieur est impliqué dans les processus de prise de décision, de motivation liée à la récompense, et de sélection de l’action. Nous avons étudié le rôle spécifique des territoires du striatum dans l’impulsivité de choix chez le singe réalisant une tâche de dévaluation temporelle. En utilisant une approche comportementale et d’imagerie, nous avons montré que le noyau caudé était impliqué dans l’impulsivité de choix induite par le Pramipexole, un agoniste dopaminergique des récepteurs D2/3. Dans une seconde étude, nous avons montré que le Méthylphénidate, un inhibiteur de recapture de la dopamine utilisé comme traitement du trouble du déficit attentionnel/hyperactivité, diminuait l’impulsivité décisionnelle en passant par une action sur le striatum ventral. En résumé, ces résultats confirment le rôle de la dopamine dans l’impulsivité décisionnelle et montrent les rôles spécifiques du noyau caudé et du striatum ventral dans les processus décisionnels liés à la dévaluation temporelle / Temporal discounting is the process by which future rewards are subjectively devalued by the decision maker. Impulsive choices, defined as the tendency to prefer small immediate rewards over larger but delayed ones, derive from a high temporal discounting. This particular dimension of impulsivity is a trait of personality, but also a symptom in many neuropsychiatric disorders. It has been shown many times that impulsive choices can be modulated by dopaminergic agents. The dopamine targets the striatum, a cerebral structure linked to cortex, subdivided into three territories – the Ventral Striatum (VS), the Caudate Nucleus (CdN) and the Putamen - and involved in motivation, goal directed behaviors, decision making and action selection. All these functions are involved in impulsive behaviors, although the specific role of each territory in impulsivity remains unknown. Here, using pharmacologic and imaging approaches, we aimed to study the role of the anterior striatum in impulsive choices using the delay discounting task in non-human primates. First, we showed that the CdN supports impulsive choices triggered by Pramipexole, a D2/3 agonist suspected to produce impulsive control disorders. In a second study, we used Methylphenidate, a blocker of dopamine transporter used in attention deficit hyperactivity disorder, and we demonstrated that the VS supports Methylphenidate therapeutic effects on impulsive choices expressed in temporal discounting task. Together, our results show that dopaminergic modulation plays a specific role on the CdN and the VS in the processes of impulsive choices, and suggest a dual action between ventral and dorsal striatal territories

Resistance against anti-malarial drugs remains one of the greatest obstacles to the effective control of malaria. The current first-line treatment regimen for uncomplicated P.falciparum malaria is based on artemisinin combination therapies (ACTs). However, reports of an increase in tolerance of the malaria parasite to artemisinins used in ACTs have alarmed the malaria community. The spread of artemisinin-resistant parasites would impact negatively on malaria control. Chloroquine and amodiaquine are 4-aminoquinolines. Chloroquine and amodiaquine were evaluated in a primate model by comparing the bioavailability of these compounds in a reference formulation and also in a Pheroid® formulation. In vivo pharmacokinetic studies were conducted for chloroquine, and in vitro and in vivo drug metabolism and pharmacokinetic (DMPK) studies were conducted for amodiaquine. Pheroid® technology forms the basis of a colloidal drug delivery system, and it is the potential application of this technology in combination with the 4-aminoquinolines that was the focus of this thesis. Pheroid® is a registered trademark but for ease of reading will be referred to as pheroid(s) or pro-pheroid(s) throughout the rest of the thesis. The non-human primate model used for evaluation of the pharmacokinetic parameters was the vervet monkey (Chlorocebus aethiops). Chloroquine was administered orally at 20 mg/kg. A sensitive and selective LC-MS/MS method was developed to analyze the concentration of chloroquine in both whole blood and plasma samples. The Cmax obtained for whole blood was 1039 ± 251.04 ng/mL for the unformulated reference sample of chloroquine and 1753.6 ± 382.8 ng/mL for the pheroid formulation. The AUC0-inf was 37365 ± 6383 ng.h/mL (reference) and 52047 ± 11210 ng.h/mL (pheroid). The results indicate that the use of pheroid technology enhances the absorption of chloroquine. The effect of pheroid technology on the bioavailability of amodiaquine and N-desethylamodiaquine was determined in two groups of vervet monkeys, with the reference group receiving capsules containing the hydrochloride salt of amodiaquine and the test group receiving capsules containing a pro-pheroid formulation of amodiaquine. Amodiaquine was administered at 60 mg/kg. Blood concentrations of amodiaquine and N-desethylamodiaquine samples were monitored over 13 time points from 0.5 to 168 hours. Amodiaquine and pro-pheroid formulated amodiaquine were incubated in vitro with human and monkey liver (HLM and MLM) and intestinal (HIM and MIM) microsomes and recombinant cytochrome P450 enzymes. The in vitro metabolism studies confirm the rapid metabolism of amodiaquine to the main metabolite N-desethylamodiaquine in monkeys. Although the pharmacokinetic parameters varied greatly, parameters for both the parent compound and main metabolite were lower in the test formulation compared to the reference formulation. For HLM, MLM and CYP2C8, the pro-pheroid test formulation showed significantly longer amodiaquine clearance and slower formation of N-desethylamodiaquine. However, the effect was reversed in MIM. Pheroid technology impacts differently on the bioavailability of the various pharmaceutical classes of anti-malarials. Pheroid technology did not enhance the bioavailability of amodiaquine or N-desethylamodiaquine. This is contrary to the observed effects of pheroid technology on the pharmacokinetics of other drugs such as artemisone and chloroquine where it increases the area under the curve and prolongs the drug half-life. / Thesis (PhD (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

Resistance against anti-malarial drugs remains one of the greatest obstacles to the effective control of malaria. The current first-line treatment regimen for uncomplicated P.falciparum malaria is based on artemisinin combination therapies (ACTs). However, reports of an increase in tolerance of the malaria parasite to artemisinins used in ACTs have alarmed the malaria community. The spread of artemisinin-resistant parasites would impact negatively on malaria control. Chloroquine and amodiaquine are 4-aminoquinolines. Chloroquine and amodiaquine were evaluated in a primate model by comparing the bioavailability of these compounds in a reference formulation and also in a Pheroid® formulation. In vivo pharmacokinetic studies were conducted for chloroquine, and in vitro and in vivo drug metabolism and pharmacokinetic (DMPK) studies were conducted for amodiaquine. Pheroid® technology forms the basis of a colloidal drug delivery system, and it is the potential application of this technology in combination with the 4-aminoquinolines that was the focus of this thesis. Pheroid® is a registered trademark but for ease of reading will be referred to as pheroid(s) or pro-pheroid(s) throughout the rest of the thesis. The non-human primate model used for evaluation of the pharmacokinetic parameters was the vervet monkey (Chlorocebus aethiops). Chloroquine was administered orally at 20 mg/kg. A sensitive and selective LC-MS/MS method was developed to analyze the concentration of chloroquine in both whole blood and plasma samples. The Cmax obtained for whole blood was 1039 ± 251.04 ng/mL for the unformulated reference sample of chloroquine and 1753.6 ± 382.8 ng/mL for the pheroid formulation. The AUC0-inf was 37365 ± 6383 ng.h/mL (reference) and 52047 ± 11210 ng.h/mL (pheroid). The results indicate that the use of pheroid technology enhances the absorption of chloroquine. The effect of pheroid technology on the bioavailability of amodiaquine and N-desethylamodiaquine was determined in two groups of vervet monkeys, with the reference group receiving capsules containing the hydrochloride salt of amodiaquine and the test group receiving capsules containing a pro-pheroid formulation of amodiaquine. Amodiaquine was administered at 60 mg/kg. Blood concentrations of amodiaquine and N-desethylamodiaquine samples were monitored over 13 time points from 0.5 to 168 hours. Amodiaquine and pro-pheroid formulated amodiaquine were incubated in vitro with human and monkey liver (HLM and MLM) and intestinal (HIM and MIM) microsomes and recombinant cytochrome P450 enzymes. The in vitro metabolism studies confirm the rapid metabolism of amodiaquine to the main metabolite N-desethylamodiaquine in monkeys. Although the pharmacokinetic parameters varied greatly, parameters for both the parent compound and main metabolite were lower in the test formulation compared to the reference formulation. For HLM, MLM and CYP2C8, the pro-pheroid test formulation showed significantly longer amodiaquine clearance and slower formation of N-desethylamodiaquine. However, the effect was reversed in MIM. Pheroid technology impacts differently on the bioavailability of the various pharmaceutical classes of anti-malarials. Pheroid technology did not enhance the bioavailability of amodiaquine or N-desethylamodiaquine. This is contrary to the observed effects of pheroid technology on the pharmacokinetics of other drugs such as artemisone and chloroquine where it increases the area under the curve and prolongs the drug half-life. / Thesis (PhD (Pharmaceutics))--North-West University, Potchefstroom Campus, 2013.

Made available in DSpace on 2015-07-22T20:50:10Z (GMT). No. of bitstreams: 0 Previous issue date: 2010-11-24 / Os primatas constituem modelos animais insubstituíveis para áreas de investigação científica devido a sua estreita relação evolutiva com os seres humanos o que assegura modelos de alta fidelidade com capacidade preditiva e discriminativa que podem não estar disponíveis em outras espécies. O Cebus apella, uma espécie de primata do novo mundo que pertence à família Cebidae, subordem Cebinae (Linnaeus, 1758), são comumente usados em pesquisas biomédicas e comportamental sendo uma espécie eleita para muitos modelos experimentais com enfoque cognitivo. O hipocampo, estrutura límbica altamente plástica situado no lóbulo temporal é importante para a aprendizagem e consolidação da memória. Desta forma, o objetivo deste estudo foi caracterizar quantitativamente e qualitativamente as células parvalbumina-positivas no hipocampo de Cebus apella, bem como estimar o volume e o número de neurônios em seus diferentes subcampos, utilizando o método do fracionador óptico. Os resultados obtidos em nosso estudo podem ser úteis para diversos projetos experimentais que tenham como foco a medicina translacional. / The nonhuman primates constitute irreplaceable animal models for research areas in which their close evolutionary relationship to humans ensures high fidelity models with predictive and discriminative abilities that may not be available in other species. The Cebus apella, a New World primate specie belonging to the Cebidae family, Cebinae suborder (Linnaeus, 1758) are commonly used in biomedical and behavior research being the specie of choice for many cognitive experimental tasks. The hippocampus, a highly plastic limbic structure situated in the temporal lobe is important for learning and memory consolidation. In this way, the aim of this study was to characterize quantitatively and qualitatively the Parvalbumin positive cells in the hippocampal formation of the Cebus monkey and also estimate the volume and neuronal number in their different subfields using an optical fractionator design method. The results obtained in our study will be useful for many experimental designs in translational medicine. / TEDE / BV UNIFESP: Teses e dissertações